Abstract 11942: Myopathy and Rhabdomyolysis With Concomitant Use of Ticagrelor and High-intensity Statins in the Elderly

Mohamed Mohamoud,Daniel Woronow,Nicole Haug,Daniel Bąk,Eileen Wu,Corinne Woods,Monica A. Muñoz,Grace Chai,Danijela Stojanovic,Ting‐Ying Huang

Abstract 11942: Myopathy and Rhabdomyolysis With Concomitant Use of Ticagrelor and High-intensity Statins in the Elderly

2019

Mohamed Mohamoud
Daniel Woronow
Nicole Haug
Daniel Bąk
Eileen Wu
Corinne Woods
Monica A. Muñoz
Grace Chai
Danijela Stojanovic
Ting‐Ying Huang

Introduction: Ticagrelor and high-intensity statins are recommended for secondary prevention of ASCVD events. We evaluated FDA Adverse Event Reporting System (FAERS) reports of myopathy/rhabdomyoly...

Keywords:

high intensity
Adverse Event Reporting System
Internal medicine
Myopathy
Ticagrelor
Medicine
Cardiology
Concomitant
Rhabdomyolysis
Diabetes mellitus
secondary prevention

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations